Lv1
80 积分 2022-01-26 加入
Breast cancer in young women
1天前
已完结
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer
16天前
已完结
Breast cancer in young women
16天前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
16天前
已完结
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2− and ADAPTcycle trials (N = 7914)
1个月前
已关闭
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
3个月前
已完结
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis
3个月前
已完结
Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
3个月前
已完结
Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
4个月前
已完结
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy
4个月前
已完结
皖公网安备34019202002308
